Vanguard Fiduciary Trust
NRXS icon

Vanguard Fiduciary Trust’s Neuraxis NRXS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Buy
59,692
+7,805
+15% +$57.6K ﹤0.01% 3321
2026
Q1 		$384K Buy
+51,887
New +$284K ﹤0.01% 3302

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust's NRXS Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Neuraxis (NRXS) stake by 15% in Q2 2026, buying an estimated $57.6K and bringing the position to 59,692 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #3321.

Vanguard Fiduciary Trust first reported a position in NRXS in Q1 2026 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Vanguard Fiduciary Trust held 59,692 shares of Neuraxis worth $436K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 7,805 Neuraxis shares in Q2 2026, an estimated $57.6K.
  • Neuraxis made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3321 holding.
  • Vanguard Fiduciary Trust first reported a position in Neuraxis in Q1 2026 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.